Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$2.55 USD
-0.05 (-1.92%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $2.54 -0.01 (-0.39%) 7:38 PM ET
3-Hold of 5 3
A Value C Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.35 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 50.00% |
ABR | 3.00 |
Earnings ESP
|
-15.09% |
---|---|
Current Year | 0.43 |
Next Year | 0.43 |
EPS (TTM) | 0.38 |
P/E (F1) | 6.05 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 71.32M | 54.02M | 216.21M | 227.51M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 71.33M | 54.34M | 216.52M | 227.91M |
Low Estimate | 71.30M | 53.70M | 215.90M | 227.10M |
Year ago Sales | 56.10M | 72.20M | 235.70M | 216.21M |
Year over Year Growth Est. | 27.12% | -25.18% | -8.27% | 5.22% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.35 | 0.15 | 0.43 | 0.43 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | 0.30 | 0.21 | 0.42 | 0.40 |
High Estimate | 0.45 | 0.21 | 0.44 | 0.74 |
Low Estimate | 0.30 | 0.08 | 0.42 | 0.15 |
Year ago EPS | 0.17 | 0.31 | 0.67 | 0.43 |
Year over Year Growth Est. | 105.88% | -51.61% | -35.82% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 2 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.35 | 0.15 | 0.43 | 0.43 |
7 Days Ago | 0.35 | 0.15 | 0.43 | 0.43 |
30 Days Ago | 0.30 | 0.23 | 0.42 | 0.43 |
60 Days Ago | 0.13 | 0.40 | 0.40 | 0.48 |
90 Days Ago | 0.13 | 0.40 | 0.40 | 0.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.30 | 0.21 | 0.42 | 0.40 |
Zacks Consensus Estimate | 0.35 | 0.15 | 0.43 | 0.43 |
Earnings ESP | -15.09% | 44.83% | -2.33% | -6.98% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.05 | 0.31 | 0.17 | NA |
Estimate | -0.10 | -0.16 | 0.37 | 0.15 | NA |
Difference | 0.05 | 0.11 | -0.06 | 0.02 | 0.03 |
Surprise | 50.00% | 68.75% | -16.22% | 13.33% | 28.97% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more